NovaBay Pharma (NBY) Misses Q4 EPS by 6c, Revenues Miss

NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($0.13), $0.06 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.07 million.

“We exited 2019 with fourth quarter Avenova unit sales at their highest level of the year, with momentum being driven by consumer sales on Amazon.com,” said Justin Hall, President and CEO of NovaBay Pharmaceuticals. “Revenue and unit sales from this channel increased each successive month since our online launch in June. By the fourth quarter, 35% of Avenova revenue and 48% of Avenova units were from Amazon.com, up from 21% and 36%, respectively, from the third quarter. While we are pleased with the results from this channel, units through Amazon.com are sold at lower gross-to-net pricing than those sold through the prescription channel, resulting in a year-over-year revenue decline for fourth quarter. Given industrywide issues with prescription reimbursement that have impacted Avenova, and the greater accessibility and improved patient experience from online sales, we view the consumer channel as the greatest opportunity for future Avenova growth.

“Our strategy this year is to enhance shareholder value by cost-effectively expanding our Avenova customer base, while leveraging our online and buy-and-sell channels with complementary product offerings and line extensions,” said Mr. Hall. “As online consumer sales become an increasing percentage of total sales of our Avenova business, we are introducing new consumer branding, with reinvigorated quality-of-life messaging and appealing packaging aimed at attracting new consumers, as now seen on Avenova.com. This refreshed branding, which highlights the ease in which Avenova can fit into people’s daily routines, is designed to appeal to a broader universe of consumers.”

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• StablecoinX reports Q2 2026 results with $34.2M net loss